Should the results for CD10 and BCL6 remain inconclusive, it may be advantageous to perform staining for BCL2, given that Burkitt lymphomas infrequently express this marker; however, it is noteworthy that certain DLBCL cases may exhibit variable expression of BCL2. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.